CD Antigens


CD (clusters of differentiation) antigens are molecules originally defined as being present on the cell surface of leucocytes and recognised by specific antibody molecules, but now including some intracellular molecules and molecules present on cells other than leucocytes. Such molecules are assigned a CD number following a consensus reached at regularly held international workshops. CD antigens include a large number of cell surface receptors, signalling molecules and adhesion molecules. Their identification is helpful in defining different populations and subpopulations of cells, particularly those of the immune system, in health and disease. Analysis of the surface phenotype of cells can be carried out on cell suspensions or using tissue sections. Methods are available for the enrichment or depletion of cells bearing a particular CD antigen, for example, from a mixed population of peripheral blood cells. CD antigens can be targeted by monoclonal antibodies for the treatment of tumours and autoimmune disease and to help limit graft rejection following transplantation.

Key Concepts

  • CD antigens are molecules that are mostly, but not exclusively, present on cell surfaces.
  • They are defined using panels of monoclonal antibodies.
  • CD designations are assigned at international workshops held every few years.
  • There are over 300 different CD antigens characterised.
  • They are mostly detected for the identification of populations and subpopulations of immune system cells.
  • In some cases, they also have utility in the identification of tumours.
  • Antibodies targeting CD antigens are used clinically in the treatment of tumours and autoimmune diseases and to limit the rejection of transplanted organs.

Keywords: leucocyte; cell surface; flow cytometry; antigen; monoclonal antibody

Figure 1. Binding of five monoclonal antibodies (mAb1–mAb5) to CD antigens on the surface of a cell. If one of the antibodies is labelled, for example, with a fluorescent dye (fluorochrome), the ability of the other antibodies to block binding of the labelled mAb can be assessed. In the example given mAb1 and mAb4 cross‐block each other suggesting that they recognise the same antigen, whereas there is no inhibition of binding of the other three mAbs.
Figure 2. Cell surface expression of CD4 and CD8 changes as early T cells develop in the thymus. Cells that are destined to become T cells initially develop in the bone marrow and then travel to the thymus. After entering the thymus, these cells lack cell surface expression of both the CD4 and CD8 molecules. They are therefore described as CD4CD8 cells. As they mature in the thymus, they go through a developmental stage during which they express both of these molecules, that is, become CD4+CD8+ T cells. Upon gaining full maturity, they lose expression of one or other of these CD antigens to become either CD4+CD8 cells (usually referred to as simply CD4+ T cells or just CD4 T cells) or CD4CD8+ cells (CD8+ T cells, CD8 T cells) before leaving the thymus. Note that there will be many thousands of CD4 and/or CD8 molecules on the surface of a single cell, not just the one molecule shown diagrammatically, and that there will also be many other molecules on the cell surface, including other CD antigens such as CD3 and CD5 (cf. Table ).
Figure 3. Diagrammatic representation of the typical course of HIV infection, characterised by a rapid decline in the number of circulating CD4+ T cells (CD4 count). A few weeks after initial infection with HIV the CD4+, T‐cell count recovers somewhat but to a lower level than before infection. No symptoms are apparent but a slow depletion of CD4+ T cells is occuring. Eventually, CD4+ T‐cell depletion is so pronounced (< 400 CD4+ T cells mm−3 peripheral blood) that immune defences are compromised and resistance to a variety of fungal, bacterial, viral and parasitic infections begins to wane, leading ultimately to progression to the acquired immunodeficiency syndrome (AIDS) once the CD4 count falls below 200 CD4+ T cells mm−3. Seroconversion refers to the time at which anti‐HIV antibodies (Abs) become detectable in peripheral blood. HIV‐specific cytotoxic T lymphocytes (CTLs), most of which are CD8+, also develop early on. Reproduced with permission from Delves PJ, Martin SJ, Burton DR and Roitt IM. Roitt's Essential Immunology. 12th Edition. 2011. © Published Wiley‐Blackwell.
Figure 4. Six‐parameter flow cytometry optical system for multicolour immunofluorescence analysis. Cell fluorescence excited by the blue laser is divided into green (fluorescein) and orange (phycoerythrin) signals, while fluorescence excited by the orange laser is reflected by a mirror and divided into near red (Texas red) and far red (allophycocyanin) signals. Blue light scattered at small forward angles and at 90° is also measured in this system, providing information on cell size and internal granularity respectively. PMT, photomultiplier tube. Reproduced with permission from Delves PJ, Martin SJ, Burton DR and Roitt IM. Roitt's Essential Immunology. 12th Edition. 2011. © Published Wiley‐Blackwell.
Figure 5. Cells that have bound labelled monoclonal antibodies (mAb) directed towards cell surface antigens can be isolated from a mixed population of cells using (a) a fluorescence‐activated cell sorter (FACS) if the antibodies have been tagged with fluorescent dyes (fluorochromes) or (b) a magnet if the antibodies have been conjugated to magnetic beads.


Adlowitz DG, Barnard J, Biear JN, et al. (2015) Expansion of activated peripheral blood memory B cells in rheumatoid arthritis, impact of B cell depletion therapy, and biomarkers of response. PLoS One 10 (6: e0128269). DOI: 10.1371/journal.pone.0128269.eCollection 2015.

Anderson KC (1995) Autologous peripheral blood progenitor cell transplantation. Journal of Clinical Apheresis 10: 131–138.

Benetti A, Berenzi A, Gambarotti M, et al. (2008) Transforming growth factor‐β1 and CD105 promote the migration of hepatocellular carcinoma‐derived endothelium. Cancer Research 68: 8626–8634.

Bernard A and Boumsell L (1984) The clusters of differentiation (CD) defined by the first international workshop on human leucocyte differentiation antigens. Human Immunology 11: 1–10.

Brelje TC, Wessendorf MW and Sorenson RL (2002) Multicolor laser scanning confocal immunofluorescence microscopy: practical application and limitations. Methods in Cell Biology 70: 165–244.

Chanmee T, Ontong P, Kimata K and Itano N (2015) Key roles of hyaluronan and its CD44 receptor in the stemness and survival of cancer stem cells. Frontiers in Oncology 5: 180. DOI: 10.3389/fonc.2015.00180.eCollection 2015.

Chattopadhyay PK and Roederer M (2005) Immunophenotyping of T cell subpopulations in HIV disease. In: Coligan JE et al. (eds) Current Protocols in Immunology, chap. 12: unit 12.12. Wiley.

Clark MC and Baum LG (2012) T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival. Annals of the New York Academy of Sciences 1253: 58–67.

Clement LT (1992) Isoforms of the CD45 common leukocyte antigen family: markers for human T‐cell differentiation. Journal of Clinical Immunology 12: 1–10.

Craig FE and Foon KA (2008) Flow cytometric immunophenotyping for hematologic neoplasms. Blood 111: 3941–3967.

Delves PJ, Martin SJ, Burton DR and Roitt IM (2011) Roitt's Essential Immunology, 12th edn. Oxford: Blackwell Science.

Edwards JC and Cambridge G (2001) Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford) 40: 205–211.

Grützkau A and Radbruch A (2010) Small but mighty: how the MACS‐technology based on nanosized superparamagnetic particles has helped to analyze the immune system within the last 20 years. Cytometry. Part A 77: 643–647.

Haselgrübler T, Haider M, Ji B, et al. (2014) High‐throughput, multiparameter analysis of single cells. Analytical and Bioanalytical Chemistry 406: 3279–3296.

Hedrick SM, Cohen DI, Nielsen EA and Davis MM (1984) Isolation of cDNA clones encoding T cell‐specific membrane‐associated proteins. Nature 308: 149–153.

Illidge T, Klein C, Sehn LH, et al. (2015) Obinutuzumab in hematologic malignancies: Lessons learned to date. Cancer Treatment Reviews 41: 784–792.

Köhler G and Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497.

Krause DS, Delelys ME and Preffer FI (2014) Flow cytometry for hematopoietic cells. Methods in Molecular Biology 1109: 23–46.

Lin F and Prichard J (eds) (2015) Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd edn. New York: Springer Science.

Lutterotti A and Martin R (2008) Getting specific: monoclonal antibodies in multiple sclerosis. Lancet Neurology 7: 538–547.

Más V and Melero JA (2013) Entry of enveloped viruses into host cells: membrane fusion. Subcellular Biochemistry 68: 467–487.

O'Gorman MR, Zollett J and Bensen N (2011) Flow cytometry assays in primary immunodeficiency diseases. Methods in Molecular Biology 699: 317–335.

Rios EJ and Kalesnikoff J (2015) FcϵRI expression and dynamics on mast cells. Methods in Molecular Biology 1220: 239–255.

Satyananda V and Shapiro R (2014) Belatacept in kidney transplantation. Current Opinion in Organ Transplantation 19: 573–577.

Schatz DG and Ji Y (2011) Recombination centres and the orchestration of V(D)J recombination. Nature Reviews Immunology 11: 251–263.

Selik RM, Mokotoff ED, Branson B, et al. (2014) Revised surveillance case definition for HIV infection‐‐United States, 2014. MMWR Recommendations and Reports 63 (RR‐03): 1–10.

Soga K, Abo H, Qin SY, et al. (2015) Mammalian cell surface display as a novel method for developing engineered lectins with novel characteristics. Biomolecules 5: 1540–1562.

Taniuchi I and Ellmeier W (2011) Transcriptional and epigenetic regulation of CD4/CD8 lineage choice. Advances in Immunology 110: 71–110.

Tonegawa S (1983) Somatic generation of antibody diversity. Nature 302: 575–581.

Trowsdale J and Knight JC (2013) Major histocompatibility complex genomics and human disease. Annual Review of Genomics and Human Genetics 14: 301–323.

Weidle UH, Scheuer W, Eggle D, et al. (2010) Cancer‐related issues of CD147. Cancer Genomics & Proteomics 7: 157–169.

Williams F and Barclay AN (1986) Glycoprotein antigens of the lymphocyte surface and their purification by antibody affinity chromatography. In: Weir DM, Herzenberg LA, Blackwell C and Herzenberg LA (eds) Handbook of Experimental Immunology, vol. 1, pp. 22.21–22.24. Oxford: Blackwell Scientific Publications.

Further Reading

Barclay AN, Brown MH, Alex Law SK, et al. (1997) The Leucocyte Antigen FactsBook, 2nd edn. London: Academic Press.

GeneCards A Searchable, Integrated, Database of Human Genes that Provides Concise Genomic Related Information, on all Known and Predicted Human Genes. (2015).

Isacke C and Horton M (2000) The Adhesion Molecule FactsBook, 2nd edn. London: Academic Press.

Lütteke T and Schwartz‐Albiez R (2012) GlycoCD: a repository for carbohydrate‐related CD antigens. Bioinformatics 28: 2553–2555.

Mason D, André P, Bensussan A, et al. (2002a) CD antigens 2002. Journal of Immunology 168: 2083–2086.

Mason D, Simmons D, Buckley C, et al. (2002b) Leucocyte Typing VII. Oxford: Oxford University Press.

Matesanz‐Isabel J, Sintes J, Llinàs L, et al. (2011) New B‐cell CD molecules. Immunology Letters 134: 104–112.

Zola H, Swart B, Nicholson I, et al. (2005) CD molecules 2005: human cell differentiation molecules. Blood 106: 3123–3126.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Delves, Peter J(Jan 2016) CD Antigens. In: eLS. John Wiley & Sons Ltd, Chichester. [doi: 10.1002/9780470015902.a0000924.pub2]